Drug
Ak150
Ak150: highest development phase Phase 1, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| AK150 NCT07566247 | Phase 1 | Advanced Malignant Solid Tumors |
Latest
No recent events.
Follow Ak150 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.